Clinical Edge Journal Scan

Beyond baseline, DBT no better than mammography for dense breasts


 

Key clinical point: In women with extremely dense breasts, digital breast tomosynthesis (DBT) does not outperform digital mammography (DM) after the initial exam.

Major finding: For baseline screening in women aged 50-59 years, recall rates per 1,000 exams dropped from 241 with DM to 204 with DBT. Cancer detection rates per 1,000 exams in this age group increased from 5.9 with DM to 8.8 with DBT. On follow-up exams, recall and cancer detection rates varied by patients’ age and breast density.

Study details: Review of 1,584,079 screenings in women aged 40-79 years.

Disclosures: The research was funded by the National Cancer Institute and the Patient-Centered Outcomes Research Institute through the Breast Cancer Surveillance Consortium. The study lead reported grants from GE Healthcare.

Source: Lowry K et al. JAMA Netw Open. 2020 Jul 1;3(7):e2011792 .

Recommended Reading

Abemaciclib cuts early recurrence in high-risk breast cancer
MDedge Hematology and Oncology
Global stomach cancer deaths decline as colorectal cancer deaths stagnate, rise
MDedge Hematology and Oncology
Divergent findings with paclitaxel and nab-paclitaxel in TNBC
MDedge Hematology and Oncology
Cancer disparities: One of the most pressing public health issues
MDedge Hematology and Oncology
The scope of under- and overtreatment in older adults with cancer
MDedge Hematology and Oncology
Radiotherapy planning scans reveal breast cancer patients’ CVD risk
MDedge Hematology and Oncology
Restarting breast cancer screening after disruption not so simple
MDedge Hematology and Oncology
AI algorithm on par with radiologists as mammogram reader
MDedge Hematology and Oncology
Study supports multigene panel testing for all breast cancer patients with second primary cancers
MDedge Hematology and Oncology
NCI may ‘kill’ major mammography trial, says adviser
MDedge Hematology and Oncology